Lanean...
Impact of (68)Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence
In this prospective survey of referring physicians, we investigated whether and how (68)Ga-labeled prostate-specific membrane antigen 11 ((68)Ga-PSMA-11) PET/CT affects the implemented management of prostate cancer patients with biochemical recurrence (BCR). Methods: We conducted a prospective surve...
Gorde:
| Argitaratua izan da: | J Nucl Med |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Society of Nuclear Medicine
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5868499/ https://ncbi.nlm.nih.gov/pubmed/29242398 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.117.202945 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|